Press Releases

Press Releases

Lexington, Mass. – January 23, 2014 – Quanterix Corporation, Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that they have been selected as a winner of the GE and NFL Head Health…
Lexington, Mass--(BUSINESS WIRE)– December 16, 2014 Quanterix, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced the opening of The Simoa Accelerator, a dedicated laboratory environment for custom assay…
LEXINGTON, MA – May 20, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that a study, prominently featuring Simoa’s multiplexing capabilities, has been published in The…
LEXINGTON, MA – August 26, 2015 Quanterix Corporation, a leader in high definition diagnostics, today announced that The Journal of Clinical Chemistry has published a new study in which its single molecule array technology (Simoa) was used to measure cardiac troponin I (cTnI) levels with both high…
January 27, 2016
Quanterix announces its expansion into several prominent APAC markets.    
May 24, 2016
Quanterix announces that the Company’s CEO and Executive Chairman, Kevin Hrusovsky, will be presenting at the 5th Annual One Mind Summit.

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more